Prognostic value of Class III B-Tubulin (TUBB3) in operable non-small cell lung cancer (NSCLC) and predictive value for adjuvant cisplatin based chemotherapy (CT): A validation study on 3 randomized trials
- Citation:
- J Clin Oncol vol 26 (May 20 suppl) abstr 7506
- Meeting Instance:
- ASCO 2008
- Year:
- 2008
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Comprehensive
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 713
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- T. Reiman P. Seve A. Vataire A. Dunant R. Rosell S. L. Graziano L. Seymour R. Pirker R. Lai
- Networks:
- Study
- CALGB-150802
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- N/A
- Keywords: